Nicola Di Meo Selected Research

Interleukin-4 Receptor alpha Subunit

5/2022

Dupilumab as promising treatment for prurigo nodularis: current evidences.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Di Meo Research Topics

Disease

4	Melanoma (Melanoma, Malignant) 06/2022 - 01/2018
4	Basal Cell Carcinoma (Rodent Ulcer) 09/2021 - 01/2018
3	COVID-19 07/2020 - 01/2020
2	Skin Neoplasms (Skin Cancer) 06/2022 - 01/2021
2	Inflammation (Inflammations) 05/2022 - 12/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 11/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 01/2020
2	Neoplasms (Cancer) 01/2019 - 01/2013
1	Prurigo 05/2022
1	Atopic Dermatitis (Atopic Eczema) 05/2022
1	Infections 01/2022
1	Erythema Multiforme 08/2021
1	Merkel Cell Carcinoma 01/2021
1	Granuloma 11/2020
1	Cutaneous Lupus Erythematosus 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Erythema 12/2019
1	Dermatitis 12/2019
1	Seborrheic Keratosis 12/2019
1	Alopecia (Baldness) 12/2019
1	Pruritus (Itching) 12/2019
1	Furunculosis (Boils) 12/2019
1	Exanthema (Rash) 12/2019
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 01/2019
1	Wounds and Injuries (Trauma) 01/2013

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2020
2	sonidegibIBA 09/2021 - 11/2020
2	secukinumabIBA 08/2021 - 01/2020
1	CytokinesIBA 05/2022
1	dupilumabIBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	InterleukinsIBA 05/2022
1	Interleukin-4 Receptor alpha SubunitIBA 05/2022
1	Interleukin-13IBA 05/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2020
1	Sunscreening Agents (Sunscreens)IBA 11/2020
1	SiliconesIBA 11/2020
1	RetinoidsIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	Doxycycline (Periostat)FDA LinkGeneric 07/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Gemcitabine FDA Link 12/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	HhAntag691IBA 01/2018

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2020
2	Immunotherapy 06/2022 - 01/2021
1	Neoadjuvant Therapy 01/2021
1	Injections 11/2020
1	Biological Therapy 01/2020
1	Drug Therapy (Chemotherapy) 12/2019
1	Surgical Amputation (Amputations) 01/2013